Rajeev M. Shah Insider Trading $RARX Ra Pharmaceuticals, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Rajeev M. Shah.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Rajeev M. Shah. Rajeev M. Shah is Director in KalVista Pharmaceuticals, Inc. ($CBYL) and in Kala Pharmaceuticals, Inc. ($KALA) and Director in Kala Pharmaceuticals, Inc. ($KALA) and Director in Ra Pharmaceuticals, Inc. ($RARX) and Director in Satsuma Pharmaceuticals, Inc. ($STSA) and Director in Black Diamond Therapeutics, Inc. ($BDTX) and Director in Solid Biosciences Inc. ($SLDB) and Director in Eidos Therapeutics, Inc. ($EIDX).
Rajeev M. Shah in Ra Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Rajeev M. Shah: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Apr 03 2020
$RARX Market Capitalization: $405.38M
$RARX Previous Close: $18.17
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Rajeev M. Shah in Ra Pharmaceuticals, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, BDTX, EIDX, KALA, KALV, RARX, STSA, SLDB
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 03 2020 | RARX | Ra Pharmaceuticals ... | Shah Rajeev M. | Director | Option Exercise | D | 19.88 | 15,000 | 298,200 | 0 | |
| Apr 03 2020 | RARX | Ra Pharmaceuticals ... | Shah Rajeev M. | Director | Option Exercise | D | 9.90 | 15,000 | 148,500 | 0 | |
| Apr 03 2020 | RARX | Ra Pharmaceuticals ... | Shah Rajeev M. | Director | Option Exercise | D | 22.37 | 15,000 | 335,550 | 0 | |
| Apr 03 2020 | RARX | Ra Pharmaceuticals ... | Shah Rajeev M. | Director | Sell | D | 48.00 | 4,858,260 | 233,196,480 | 0 | 4.9 M to 0 (-100.00 %) |
| Jun 13 2019 | RARX | Ra Pharmaceuticals ... | Shah Rajeev M. | Director | Option Exercise | A | 19.88 | 15,000 | 298,200 | 15,000 | |
| Dec 14 2018 | RARX | Ra Pharmaceuticals ... | Shah Rajeev M. | Director | Buy | P | 15.50 | 1,006,452 | 15,600,006 | 4,858,260 | 3.9 M to 4.9 M (+26.13 %) |
| Jul 02 2018 | RARX | Ra Pharmaceuticals ... | Shah Rajeev M. | Director | Option Exercise | A | 9.90 | 15,000 | 148,500 | 15,000 | |
| Feb 16 2018 | RARX | Ra Pharmaceuticals ... | Shah Rajeev M. | Director | Buy | P | 6.00 | 2,500,000 | 15,000,000 | 3,851,808 | 1.4 M to 3.9 M (+184.94 %) |
| Jun 22 2017 | RARX | Ra Pharmaceuticals ... | Shah Rajeev M. | Director | Option Exercise | A | 22.37 | 15,000 | 335,550 | 15,000 | |
| Oct 31 2016 | RARX | Ra Pharmaceuticals ... | Shah Rajeev M. | Director | Option Exercise | C | 0.00 | 4,015,378 | 0 | 0 | |
| Oct 31 2016 | RARX | Ra Pharmaceuticals ... | Shah Rajeev M. | Director | Option Exercise | C | 0.00 | 4,316,531 | 0 | 0 | |
| Oct 31 2016 | RARX | Ra Pharmaceuticals ... | Shah Rajeev M. | Director | Buy | P | 13.00 | 161,538 | 2,099,994 | 1,351,808 | 1.2 M to 1.4 M (+13.57 %) |
| Oct 31 2016 | RARX | Ra Pharmaceuticals ... | Shah Rajeev M. | Director | Buy | C | 0.00 | 573,624 | 0 | 1,190,270 | 616.6 K to 1.2 M (+93.02 %) |
| Oct 31 2016 | RARX | Ra Pharmaceuticals ... | Shah Rajeev M. | Director | Buy | C | 0.00 | 616,646 | 0 | 616,646 | 0 to 616.6 K |
Page: 1